Taro Pharmaceutical Industries Ltd (TARO) is lower by Wednesday morning, with the stock declining -4.69% in pre-market trading to 39.99.
TARO's short-term technical score of 96 indicates that the stock has traded more bullishly over the last month than 96% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 105 out of 146 industries, Taro Pharmaceutical Industries Ltd ranks higher than 95% of stocks.
Taro Pharmaceutical Industries Ltd has fallen 1.69% over the past month, closing at $42.42 on February 7. During this period of time, the stock fell as low as $41.98 and as high as $43.05. TARO has an average analyst recommendation of Sell. The company has an average price target of $43.00.
TARO has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on TARO!
Taro Pharmaceutical Industries Ltd has a Long-Term Technical rank of 54. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 46% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 110 by this metric, TARO ranks better than 110% of stocks.
